Wisconsin radio broadcasters Paul Braun, Mike Heller, Matt Lepay, Jim Paschke and Brian Posick are teaming up to raise money and awareness for Alzheimer’s disease research at the University of Wisconsin–Madison.
WAI News
Dr. Jessica Caldwell explores gender differences in Alzheimer’s disease as new WRAP study leader
Globally, Alzheimer’s disease impacts women at a much higher rate than men. In the United States, two-thirds of the 6.2 million people living with Alzheimer’s disease are women. Understanding these gender and sex differences – and ultimately preventing Alzheimer’s disease and related dementia – is at the root of the pioneering work of Jessica Caldwell, PhD, a new faculty member in the University of Wisconsin–Madison Alzheimer’s disease programs.
Latinos often face symptoms earlier, but are less likely to receive dementia diagnosis
In an interview on Telemundo Wisconsin, Maria Mora Pinzon, MD, MS, a physician and the implementation science leader at the Wisconsin Alzheimer’s Institute, shed light on the alarming disparities in dementia diagnosis and care affecting Latino communities. She described research which has found that although Latinos are disproportionately impacted by Alzheimer’s disease, they are the least likely to be informed of their diagnosis.
Thank you for joining us at Info Sessions!
That’s a wrap on our 2025 WRAP Info Sessions events. Thank you to the hundreds of participants who joined us in person for a Info Session event held in September and October in five locations in Wisconsin.
UW–Madison Alzheimer’s disease researchers present new findings at 2025 international conference
A team of researchers from the Wisconsin Alzheimer’s Institute joined nearly 19,000 global experts at the 2025 Alzheimer’s Association International Conference (AAIC), held July 27-July 31 in Toronto, Canada.
Two leading dementia researchers join UW–Madison
UW–Madison’s School of Medicine and Public Health is adding Henrik Zetterberg, a Swedish scientist who studies biomarkers, and Hartmuth Kolb, a German-born chemist and expert in imaging technology, to its faculty.
Bringing memory care strategy and tools to primary care clinics
Researchers in the public health team at Wisconsin Alzheimer’s Institute are working to understand how to bring research advances and tools from memory clinics into the primary care environment.
Dr. Maria Mora Pinzon leads education program to train medical students in advancing dementia care for Latinos
Researchers in Madison are partnering with a Milwaukee-based Latino community center to create a new, culturally competent, elective course for medical students at the University of Wisconsin School of Medicine and Public Health as an elective.
Dr. Nathaniel Chin discusses UW–Madison role in Alzheimer’s blood tests on regional media outlets
Nathaniel Chin, MD, medical director of the WRAP study, appeared on numerous Wisconsin news outlets to discuss the recent Food and Drug Administration (FDA) approval of a blood test for Alzheimer’s disease. The accuracy of the blood test was validated using data samples from the Wisconsin Alzheimer’s Disease Research Center (ADRC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP).
UW–Madison research helps launch first FDA-cleared blood test for Alzheimer’s disease
In a crucial advancement for Alzheimer’s disease diagnosis, the U.S. Food and Drug Administration (FDA) granted clearance for an Alzheimer’s disease blood test on May 16, 2025. The test is an in vitro diagnostic (IVD) assay capable of detecting amyloid — a key protein involved in Alzheimer’s disease — in blood. Data samples used to evaluate the validity of the test are from research conducted at the University of Wisconsin–Madison.